Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 2 of the 28 sources its claims cite were checked for support.
Abstract
In Plasmodium falciparum-endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.
Overview
CoChat Summary
TL;DR
This study provides evidence that VAR2CSA is expressed on the surface of CSA-selected *Plasmodium falciparum*–infected erythrocytes and is recognized by plasma IgG in a sex-specific and parity-dependent manner characteristic of pregnancy-associated malaria. High anti-VAR2CSA IgG levels were associated with markedly heavier babies and lower risk of low birth weight in women with active-chronic placental infection.
Key findings
- Rabbit antisera against VAR2CSA DBL5-ε and DBL1-X labeled the surface of CSA-selected, VSAPAM-expressing parasite lines by flow cytometry and confocal microscopy, but did not label isogenic lines not expressing VSAPAM.
- VAR2CSA-specific IgG levels were higher in women than men: for DBL5-ε, median difference [95% CI] was 0.14 [0.081–0.27] in one Ghanaian panel and 2.34 [1.46–2.59] in a separate term-pregnant-women/men panel; both P < 0.001. Levels also correlated with parity (rs = 0.38, P = 0.0027; P = 0.03 in a model including parity and age).
- Among 110 Kenyan women with histological active-chronic placental *P. falciparum* infection, high above-median VAR2CSA DBL5-ε IgG was associated with a fourfold lower risk of low birth weight (<2.500 g): odds ratio 0.25 [95% CI 0.10–0.63], P = 0.003.
- Women with high VAR2CSA DBL5-ε IgG delivered babies weighing 2.864 g (95% CI 2.700–3.029 g) versus 2.436 g (95% CI 2.264–2.608 g) for women with low levels.
Methods
- Recombinant VAR2CSA domains DBL1-X and DBL5-ε were produced from a synthetic 3D7 *var2csa* gene; rabbit antisera were raised against these proteins, with VAR4 DBL5-δ and GLURP used as control antigens.
- Plasma panels came from Ghanaian individuals exposed to hyperendemic seasonal or stable *P. falciparum* transmission: 39 men and 46 women; 30 men and 27 term-pregnant women; 62 pregnant women at delivery; plus 110 Kenyan women with active-chronic placental infection and six unexposed negative controls.
- Parasite lines NF54 and FCR3 were selected for CSA adhesion or for VAR2CSA DBL5-ε IgG binding; surface reactivity was assessed by flow cytometry and confocal microscopy, antibody levels by ELISA, and associations by Mann-Whitney, Spearman correlation, and logistic regression.
Limitations
- The paper does not state a limitations section. Evident from the text: the birth-weight analysis is observational and restricted to 110 Kenyan women with active-chronic placental infection, so causality and broader generalizability are not established.
- Evident from the text: CSA-selected NF54 showed a double peak, with only approximately half the parasites expressing VAR2CSA, requiring additional antibody-based selection; this indicates heterogeneity in VAR2CSA expression among CSA-selected parasites.
- Evident from the text: the study demonstrates surface expression and serological association but does not directly show that VAR2CSA itself mediates CSA binding or that anti-VAR2CSA IgG blocks placental adhesion.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
2 Valid · 0 Not valid · 13 Not checked · 31 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, sex-specific and parity-dependent plasma IgG recognition of IEs after Saimiri brain endothelial cell selection has not been reported, but domains from VAR1CSA do not show the expected VSAPAM-type sex-specific and parity-dependent IgG recognition (30).”
§ Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria > Results and Discussion
What the sources say
- Supportedcites [30] 2003, Infect. Immun. source
The citation (30) is attached to the second clause, and our copy of Jensen et al. (2003) states exactly that: the abstract reports that 'antibody recognition of recombinant products of a specific VSA gene (2O2var1) implicated in PAM ... did not have these characteristics', and the Results (Fig. 2 discussion) state 'in no case was there any significant difference in reactivity between plasma samples from malaria-exposed males and females, and there was no evidence of parity dependency of any of the domain-specific antibody reactivities (P > 0.05)', against gender-specific and parity-dependent recognition of native VSAPAM on 2O2-CSA (Fig. 1). The paper designates the gene 2O2var1 (a var1-type/CSA-implicated gene) rather than 'VAR1CSA', a nomenclature difference only. The first clause — that sex-specific/parity-dependent IgG recognition after Saimiri brain endothelial cell selection has not been reported — is not carried by this citation and is not addressed in our copy, which used CSA-adherence selection (2O2-CSA) rather than Saimiri selection. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In contrast, GLURP-specific IgG levels did not depend significantly on parity (P = 0.94; unpublished data).”
§ Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria > Results and Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The double peak in the flow diagram of anti-VAR2CSA–labeled CSA-selected NF54 (Figs. 1 a and 2 a) indicated that approximately half of these parasites expressed VAR2CSA”
§ Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria > Results and Discussion
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we show that 3D7 VAR2CSA-specific antisera labeled different CSA-selected parasite lines (Fig. 1)”
§ Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria > Results and Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Logistic regression analysis showed that high (i.e., above median) plasma levels of VAR2CSA DBL5-ɛ–specific plasma IgG were associated with a fourfold lower risk of giving birth to a seriously underweight (<2.500 g) infant (Table I).”
- Also stated in: § Results and Discussion · plain
“VAR2CSA DBL5-ɛ IgG > median | 0.25 [0.10–0.63] | 0.003”
§ Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria > Results and Discussion
plainstates an associationn = 110- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results and Discussion · plain
24 more claims
Create a free account to see all 46 claims and to verify the 3 references still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 11
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“VAR2CSA is preferentially expressed by placental parasites and isolates selected to bind CSA [14,15], and is currently the leading candidate for a vaccine to prevent malaria during pregnancy.”
From Designing a VAR2CSA-based vaccine to prevent placental malaria (2015) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The binding of the variant surface antigen (VAR2CSA) with chondroitin sulphate A has been implicated in the pathology of falciparum malaria in pregnancy.65–68”
From Malaria in pregnancy. (2013) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Levels of anti-VAR2CSA specific IgGs increase with parity, cannot be found in men and are associated with a favourable pregnancy outcome 64–66 so that the malaria risk decreases with increasing parity.”
From Malaria in pregnancy. (2013) · cites this paper as [65]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Infected erythrocyte (IE) adhesion to CSA is mediated by VAR2CSA, a member of the P. falciparum erythrocyte membrane protein family (PfEMP1) that is preferentially expressed by placental parasites and parasites selected to bind CSA [3–5].”
From Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes (2018) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Levels of anti-DBL5ε IgG have also been positively associated with birth weight, again indicating their protective effect [6].”
From Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area (2010) · cites this paper as [6]
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108
Pushing the limits of the scanning mechanism for initiation of translation
Kozak, M. (2002) · Gene · doi:10.1016/s0378-1119(02)01056-9 · Cited by 919
An analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed · Cited by 782
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen, A. T. R., Sowa, M. P. K., Arnot, D. E., Hviid, L., & Theander, T. G. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03570.x · Cited by 702
Self-citationMaternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659
Lavstsen, T., Salanti, A., Jensen, A. T., Arnot, D. E., & Theander, T. G. (2003) · Malaria Journal · doi:10.1186/1475-2875-2-27 · Cited by 347
Self-citationJensen, A. T. R., Magistrado, P., Sharp, S., Joergensen, L., Lavstsen, T., Chiucchiuini, A., Salanti, A., Vestergaard, L. S., Lusingu, J. P., Hermsen, R., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040274 · Cited by 322
Self-citationRicke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
Self-citation
Research works printed but not linked: 1
- 1983, Bull. World Health Organ., 61, 1005
Cited by
Malaria in pregnancy: pathogenesis and immunity
Rogerson, S. J., Hviid, L., Duffy, P. E., Leke, R. F., & Taylor, D. W. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70022-1 · Cited by 628
Self-citationSevere malaria is associated with parasite binding to endothelial protein C receptor
Turner, L., Lavstsen, T., Berger, S. S., Wang, C. W., Petersen, J. E. V., Avril, M., Brazier, A. J., Freeth, J., Jespersen, J. S., Nielsen, M. A., et al. (2013) · Nature · doi:10.1038/nature12216 · Cited by 559
Self-citationMaier, A. G., Rug, M., O'Neill, M. T., Brown, M., Chakravorty, S., Szestak, T., Chesson, J., Wu, Y., Hughes, K., Coppel, R. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.051 · Cited by 517
Immune effector mechanisms in malaria
MARSH, K., & KINYANJUI, S. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00808.x · Cited by 419
Self-citationPlasmodium falciparum Erythrocyte Membrane Protein 1 Diversity in Seven Genomes – Divide and Conquer
Rask, T. S., Hansen, D. A., Theander, T. G., Gorm Pedersen, A., & Lavstsen, T. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000933 · Cited by 372
Self-citationCommon strategies for antigenic variation by bacterial, fungal and protozoan pathogens
Deitsch, K. W., Lukehart, S. A., & Stringer, J. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2145 · Cited by 375
Thrombomodulin and its role in inflammation
Conway, E. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0282-8 · Cited by 322
PTEX is an essential nexus for protein export in malaria parasites
Elsworth, B., Matthews, K., Nie, C. Q., Kalanon, M., Charnaud, S. C., Sanders, P. R., Chisholm, S. A., Counihan, N. A., Shaw, P. J., Pino, P., et al. (2014) · Nature · doi:10.1038/nature13555 · Cited by 269
A family affair: var genes, PfEMP1 binding, and malaria disease
Kraemer, S. M., & Smith, J. D. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.006 · Cited by 287
Plasmodium asexual growth and sexual development in the haematopoietic niche of the host
Venugopal, K., Hentzschel, F., Valkiūnas, G., & Marti, M. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0306-2 · Cited by 264
Lavstsen, T., Turner, L., Saguti, F., Magistrado, P., Rask, T. S., Jespersen, J. S., Wang, C. W., Berger, S. S., Baraka, V., Marquard, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120455109 · Cited by 269
Self-citationVariant surface antigens of Plasmodium falciparum and their roles in severe malaria
Wahlgren, M., Goel, S., & Akhouri, R. R. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.47 · Cited by 235
Smith, J. D., Rowe, J. A., Higgins, M. K., & Lavstsen, T. (2013) · Cellular Microbiology · doi:10.1111/cmi.12183 · Cited by 225
Self-citationBRIAN de SOUZA, J., HAFALLA, J. C. R., RILEY, E. M., & COUPER, K. N. (2010) · Parasitology · doi:10.1017/s0031182009991715 · Cited by 229
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Salanti, A., Clausen, T. M., Agerbæk, M. Ø., Al Nakouzi, N., Dahlbäck, M., Oo, H. Z., Lee, S., Gustavsson, T., Rich, J. R., Hedberg, B. J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.003 · Cited by 220
Self-citationRottmann, M., Lavstsen, T., Mugasa, J. P., Kaestli, M., Jensen, A. T. R., Müller, D., Theander, T., & Beck, H.-P. (2006) · Infection and Immunity · doi:10.1128/iai.02073-05 · Cited by 212
Self-citationThe future for blood‐stage vaccines against malaria
Richards, J. S., & Beeson, J. G. (2009) · Immunology & Cell Biology · doi:10.1038/icb.2009.27 · Cited by 215
Kyriacou, H. M., Stone, G. N., Challis, R. J., Raza, A., Lyke, K. E., Thera, M. A., Koné, A. K., Doumbo, O. K., Plowe, C. V., & Rowe, J. A. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.08.005 · Cited by 210
Kraemer, S. M., Kyes, S. A., Aggarwal, G., Springer, A. L., Nelson, S. O., Christodoulou, Z., Smith, L. M., Wang, W., Levin, E., Newbold, C. I., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-45 · Cited by 203
Viebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400466 · Cited by 201
Fried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
Lau, C. K. Y., Turner, L., Jespersen, J. S., Lowe, E. D., Petersen, B., Wang, C. W., Petersen, J. E. V., Lusingu, J., Theander, T. G., Lavstsen, T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.007 · Cited by 188
Self-citationMalaria in Pregnancy: Linking Immunity and Pathogenesis to Prevention
Rogerson, S. J., Mwapasa, V., & Meshnick, S. R. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.77.6.suppl.14 · Cited by 188
Avril, M., Tripathi, A. K., Brazier, A. J., Andisi, C., Janes, J. H., Soma, V. L., Sullivan, D. J., Bull, P. C., Stins, M. F., & Smith, J. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120534109 · Cited by 184
Kyes, S. A., Kraemer, S. M., & Smith, J. D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00173-07 · Cited by 170
High Level of var2csa Transcription by Plasmodium falciparum Isolated from the Placenta
Tuikue Ndam, N. G., Salanti, A., Bertin, G., Dahlbäck, M., Fievet, N., Turner, L., Gaye, A., Theander, T., & Deloron, P. (2005) · The Journal of Infectious Diseases · doi:10.1086/430933 · Cited by 179
Self-citationTakem, E. N., & D'Alessandro, U. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.010 · Cited by 185
Clausen, T. M., Christoffersen, S., Dahlbäck, M., Langkilde, A. E., Jensen, K. E., Resende, M., Agerbæk, M. Ø., Andersen, D., Berisha, B., Ditlev, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348839 · Cited by 173
“Evidence suggests that VAR2CSA is the main target of this protective immunity (9).”
BackgroundSelf-citation(2015) · Advances in Parasitology · doi:10.1016/bs.apar.2015.02.004 · Cited by 162
Self-citationJensen, A. R., Adams, Y., & Hviid, L. (2020) · Immunological Reviews · doi:10.1111/imr.12807 · Cited by 158
Self-citationChan, J.-A., Fowkes, F. J. I., & Beeson, J. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1614-3 · Cited by 168
Chang, C. C., Crane, M., Zhou, J., Mina, M., Post, J. J., Cameron, B. A., Lloyd, A. R., Jaworowski, A., French, M. A., & Lewin, S. R. (2013) · Immunological Reviews · doi:10.1111/imr.12063 · Cited by 163
Trimnell, A. R., Kraemer, S. M., Mukherjee, S., Phippard, D. J., Janes, J. H., Flamoe, E., Su, X.-Z., Awadalla, P., & Smith, J. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.012 · Cited by 165
Mordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154
Self-citationAgerbæk, M. Ø., Bang-Christensen, S. R., Yang, M.-H., Clausen, T. M., Pereira, M. A., Sharma, S., Ditlev, S. B., Nielsen, M. A., Choudhary, S., Gustavsson, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05793-2 · Cited by 160
Self-citationSrivastava, A., Gangnard, S., Round, A., Dechavanne, S., Juillerat, A., Raynal, B., Faure, G., Baron, B., Ramboarina, S., Singh, S. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000951107 · Cited by 149
Variant Gene Expression and Antigenic Variation by Malaria Parasites
Deitsch, K., & Dzikowski, R. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093841 · Cited by 145
Franke-Fayard, B. M. D., Fonager, J., Braks, A. A. M., Khan, S. M., & Janse, C. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001032 · Cited by 146
Cell biology and immunology of malaria
Hafalla, J. C. R., Silvie, O., & Matuschewski, K. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00988.x · Cited by 185
Naturally acquired immunity to Plasmodium falciparum malaria in Africa
Hviid, L. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.06.012 · Cited by 163
Self-citationJoergensen, L., Bengtsson, D. C., Bengtsson, A., Ronander, E., Berger, S. S., Turner, L., Dalgaard, M. B., Cham, G. K. K., Victor, M. E., Lavstsen, T., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001083 · Cited by 138
Self-citationRecent insights into humoral and cellular immune responses against malaria
Beeson, J. G., Osier, F. H. A., & Engwerda, C. R. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.08.008 · Cited by 118
Malaria vaccines: a new era of prevention and control
Duffy, P. E., Gorres, J. P., Healy, S. A., & Fried, M. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01065-7 · Cited by 143
Khunrae, P., Dahlbäck, M., Nielsen, M. A., Andersen, G., Ditlev, S. B., Resende, M., Pinto, V. V., Theander, T. G., Higgins, M. K., & Salanti, A. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.040 · Cited by 121
Self-citationFunctional Antibodies and Protection against Blood-stage Malaria
Teo, A., Feng, G., Brown, G. V., Beeson, J. G., & Rogerson, S. J. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.07.003 · Cited by 131
A plethora of Plasmodium species in wild apes: a source of human infection?
Rayner, J. C., Liu, W., Peeters, M., Sharp, P. M., & Hahn, B. H. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.006 · Cited by 135
Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice
Zhang, B., Tan, L., Yu, Y., Wang, B., Chen, Z., Han, J., Li, M., Chen, J., Xiao, T., Ambati, B. K., et al. (2018) · Theranostics · doi:10.7150/thno.22904 · Cited by 128
Cham, G. K. K., Turner, L., Lusingu, J., Vestergaard, L. S., Mmbando, B. P., Kurtis, J. D., Jensen, A. T. R., Salanti, A., Lavstsen, T., & Theander, T. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901331 · Cited by 124
Self-citationBockhorst, J., Lu, F., Janes, J. H., Keebler, J., Gamain, B., Awadalla, P., Su, X.-Z., Samudrala, R., Jojic, N., & Smith, J. D. (2007) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2007.06.007 · Cited by 117
Protein Export into Malaria Parasite–Infected Erythrocytes: Mechanisms and Functional Consequences
Spillman, N. J., Beck, J. R., & Goldberg, D. E. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034157 · Cited by 117
Barfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110
“…among CSAadhering and placental isolates, VAR2CSA is exposed on the surface of CSA-adhering IEs (Salanti et al., 2003; 2004; Tuikue Ndam et al., 2005), and plasma levels of VAR2CSA-specific IgG increase with increasing parity and correlate with protective immunity to PAM (Salanti et al., 2004).”
BackgroundMethodInfluentialSelf-citationDuffy, M. F., Maier, A. G., Byrne, T. J., Marty, A. J., Elliott, S. R., O’Neill, M. T., Payne, P. D., Rogerson, S. J., Cowman, A. F., Crabb, B. S., et al. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.006 · Cited by 126
Amulic, B., Salanti, A., Lavstsen, T., Nielsen, M. A., & Deitsch, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000256 · Cited by 114
Self-citationPlacental Malaria: A New Insight into the Pathophysiology
Sharma, L., & Shukla, G. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00117 · Cited by 139
Transcribed var Genes Associated with Placental Malaria in MalawianWomen
Duffy, M. F., Caragounis, A., Noviyanti, R., Kyriacou, H. M., Choong, E. K., Boysen, K. E., Healer, J., Rowe, J. A., Molyneux, M. E., Brown, G. V., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01978-05 · Cited by 114
Pereira, M. A., Clausen, T. M., Pehrson, C., Mao, Y., Resende, M., Daugaard, M., Kristensen, A. R., Spliid, C. B., Mathiesen, L., Knudsen, L. E., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005831 · Cited by 123
Self-citationNew Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women
Fowkes, F. J., McGready, R., Cross, N. J., Hommel, M., Simpson, J. A., Elliott, S. R., Richards, J. S., Lackovic, K., Viladpai-Nguen, J., Narum, D., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis566 · Cited by 101
The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria
Higgins, M. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800086200 · Cited by 106
Bull, P. C., Buckee, C. O., Kyes, S., Kortok, M., Thathy, V., Guyah, B., Stoute, J. A., Newbold, C., & Marsh, K. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06248.x · Cited by 101
Self-citationProtective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
Self-citationTherapeutic and Safety Considerations of Nanoparticle-Mediated Drug Delivery in Pregnancy
Keelan, J. A., Leong, J. W., Ho, D., & Iyer, K. S. (2015) · Nanomedicine · doi:10.2217/nnm.15.48 · Cited by 102
Dahlbäck, M., Rask, T. S., Andersen, P. H., Nielsen, M. A., Ndam, N. T., Resende, M., Turner, L., Deloron, P., Hviid, L., Lund, O., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020124 · Cited by 98
Self-citationDuffy, M. F., Byrne, T. J., Elliott, S. R., Wilson, D. W., Rogerson, S. J., Beeson, J. G., Noviyanti, R., & Brown, G. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04577.x · Cited by 93
Cutts, J. C., Agius, P. A., Lin, Z., Powell, R., Moore, K. A., Draper, B. L., Simpson, J. A., & Fowkes, F. J. I. (2020) · BMC Medicine · doi:10.1186/s12916-019-1467-6 · Cited by 102
Nielsen, M. A., Pinto, V. V., Resende, M., Dahlbäck, M., Ditlev, S. B., Theander, T. G., & Salanti, A. (2009) · Infection and Immunity · doi:10.1128/iai.00159-09 · Cited by 92
“The antigen is expressed on the surface of IE panned on CSA in vitro and on ex vivo IE isolated from infected placentas (13, 19).”
BackgroundInfluentialSelf-citationMolecular Epidemiology of Malaria
Conway, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-06 · Cited by 119
Dynamics of Anti‐VAR2CSA Immunoglobulin G Response in a Cohort of Senegalese Pregnant Women
Tuikue Ndam, N. G., Salanti, A., Le‐Hesran, J. ‐., Cottrell, G., Fievet, N., Turner, L., Sow, S., Dangou, J. ‐., Theander, T., & Deloron, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500146 · Cited by 89
Self-citationDesigning a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
“Among Kenyan women with acute or chronic malaria infection, higher antibody levels to DBL5 were associated with reduced risk of low birthweight delivery and with increased birthweight [14].”
BackgroundThe Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Dahlbäck, M., Jørgensen, L. M., Nielsen, M. A., Clausen, T. M., Ditlev, S. B., Resende, M., Pinto, V. V., Arnot, D. E., Theander, T. G., & Salanti, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191510 · Cited by 95
Self-citationCham, G. K. K., Turner, L., Kurtis, J. D., Mutabingwa, T. K., Fried, M., Jensen, A. T. R., Lavstsen, T., Hviid, L., Duffy, P. E., & Theander, T. G. (2010) · Infection and Immunity · doi:10.1128/iai.00593-10 · Cited by 85
Self-citationOuattara, A., & Laurens, M. B. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu954 · Cited by 85
Barfod, L. K., Dalgaard, M. B., Pleman, S. T., Ofori, M. F., Pleass, R. J., & Hviid, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103708108 · Cited by 89
Self-citationVaccine development against malaria
Matuschewski, K. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.004 · Cited by 90
Mkumbaye, S. I., Wang, C. W., Lyimo, E., Jespersen, J. S., Manjurano, A. M., Mosha, J. F., Kavishe, R. A., Mwakalinga, S., Minja, D. T. R., Lusingu, J., et al. (2017) · Infection and Immunity · doi:10.1128/iai.00841-16 · Cited by 98
Self-citationGhumra, A., Semblat, J., Ataíde, R., Kifude, C., Adams, Y., Claessens, A., Anong, D. N., Bull, P. C., Fennell, C., Arman, M., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002665 · Cited by 87
Malaria: modification of the red blood cell and consequences in the human host
Moxon, C. A., Grau, G. E., & Craig, A. G. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08755.x · Cited by 115
Default Pathway of var2csa Switching and Translational Repression in Plasmodium falciparum
Mok, B. W.-Y., Ribacke, U., Rasti, N., Kironde, F., Chen, Q., Nilsson, P., & Wahlgren, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001982 · Cited by 86
Davies, H. M., Belda, H., Broncel, M., Ye, X., Bisson, C., Introini, V., Dorin, D., Semblat, J., Tibúrcio, M., Gamain, B., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0702-4 · Cited by 84
Var2CSA minimal CSA binding region is located within the N-terminal region
Srivastava, A., Gangnard, S., Dechavanne, S., Amirat, F., Lewit Bentley, A., Bentley, G. A., & Gamain, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020270 · Cited by 76
“protection against malaria during pregnancy [11,18,19,20].”
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79
Self-citationMalaria, primigravidae, and antibodies: knowledge gained and future perspectives
Ataíde, R., Mayor, A. G., & Rogerson, S. J. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2013.12.007 · Cited by 83
Frank, M., Kirkman, L. A., Costantini, D., Sanyal, S., Lavazec, C., Templeton, T. J., & Deitsch, K. (2008) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.01.010 · Cited by 76
Hviid, L. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9602 · Cited by 75
Self-citationStructural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.
Ma, R., Lian, T., Huang, R., Renn, J. P., Petersen, J. D., Zimmerberg, J., Duffy, P. E., & Tolia, N. H. (2021) · Nature Microbiology · doi:10.1038/s41564-020-00858-9 · Cited by 72
Clausen, T. M., Pereira, M. A., Nakouzi, N. A., Oo, H. Z., Agerbæk, M. Ø., Lee, S., Ørum-Madsen, M. S., Kristensen, A. R., El-Naggar, A. M., Grandgenett, P. M., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0103 · Cited by 78
Self-citationAnalyzing computer based patient records: a review of literature.
Erstad, T. L. (2003) · PubMed · Cited by 92
Variant antigen gene expression in malaria
Dzikowski, R., Templeton, T. J., & Deitsch, K. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00760.x · Cited by 80
Birch, C. M., Hou, H. W., Han, J., & Niles, J. C. (2015) · Scientific Reports · doi:10.1038/srep11347 · Cited by 71
Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities
Birkett, A. J., Moorthy, V., Loucq, C., Chitnis, C. E., & Kaslow, D. C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.040 · Cited by 75
High Avidity Antibodies to Full-Length VAR2CSA Correlate with Absence of Placental Malaria
Tutterrow, Y. L., Salanti, A., Avril, M., Smith, J. D., Pagano, I., Ako, S. E., Fogako, J., Leke, R. G. F., & Taylor, D. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040049 · Cited by 75
Self-citationContributions of natural killer cells to the immune response against Plasmodium
Burrack, K. S., Hart, G. T., & Hamilton, S. E. (2019) · Malaria Journal · doi:10.1186/s12936-019-2953-1 · Cited by 75
The Promise of a Malaria Vaccine—Are We Closer?
Laurens, M. B. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062427 · Cited by 77
Asexual blood-stage malaria vaccine development: facing the challenges
Genton, B., & Reed, Z. H. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282dd7a29 · Cited by 79
Elliott, S. R., Brennan, A. K., Beeson, J. G., Tadesse, E., Molyneux, M. E., Brown, G. V., & Rogerson, S. J. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5903-5907.2005 · Cited by 79
Intermittent preventive treatment against malaria: an update
Gosling, R. D., Cairns, M. E., Chico, R. M., & Chandramohan, D. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.36 · Cited by 75
Oleinikov, A. V., Amos, E., Frye, I. T., Rossnagle, E., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000386 · Cited by 72
VAR2CSA and protective immunity against pregnancy-associatedPlasmodium falciparummalaria
Hviid, L., & Salanti, A. (2007) · Parasitology · doi:10.1017/s0031182007000121 · Cited by 80
Self-citationRasti, N., Namusoke, F., Chêne, A., Chen, Q., Staalsoe, T., Klinkert, M.-Q., Mirembe, F., Kironde, F., & Wahlgren, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601519103 · Cited by 69
Promising nanomaterials in the fight against malaria
Borgheti-Cardoso, L. N., Anselmo, M. S., Lantero, E., Lancelot, A., Serrano, J. L., Hernández‐Ainsa, S., Fernàndez‐Busquets, X., & Sierra, T. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01398f · Cited by 76
Ralph, S. A., Bischoff, E., Mattei, D., Sismeiro, O., Dillies, M., Guigon, G., Coppée, J., David, P. H., & Scherf, A. (2005) · Genome biology · doi:10.1186/gb-2005-6-11-r93 · Cited by 72
Metadata
- Authors
- Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., Hviid, L., & Theander, T. G.
- Affiliations
- University of Copenhagen (DK)
- 1Centre for Medical Parasitology, Department of Medical Microbiology and Immunology, University of Copenhagen
- University of Ghana (GH)
- Kenya Medical Research Institute (KE)
- Corresponding author
- Salanti, Ali
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2004-11-01
- Volume
- 200
- Issue
- 9
- Pages
- 1197-1203
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2211857
- OpenAlex
- W2139449809
- Cited by
- 604
- References
- 30
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 31 · 2022: 28 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 25 · 2017: 43 · 2016: 24 · 2015: 32 · 2014: 31 · 2013: 27 · 2012: 26
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- European Commission
- Medical Research Council
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- malaria in pregnancy, VAR2CSA, Plasmodium falciparum, variant surface antigens, chondroitin sulfate A, placental malaria, low birth weight
- MeSH terms
- Africa, Birth Weight, Chondroitin Sulfates, Enzyme-Linked Immunosorbent Assay, Erythrocytes, Female, Humans, Immunoglobulin G, Male, Placenta, Pregnancy, Recombinant Proteins, Sex Factors, Protozoan Proteins, Malaria, Falciparum, DNA Primers, Microscopy, Confocal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.